Henry Ford Hospital Medical Journal
Volume 20 | Number 2

Article 6

6-1972

Postmenopausal Osteoporosis: The evolution of
our concepts of its cause
Harold M. Frost

Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal
Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health
Commons
Recommended Citation
Frost, Harold M. (1972) "Postmenopausal Osteoporosis: The evolution of our concepts of its cause," Henry Ford Hospital Medical
Journal : Vol. 20 : No. 2 , 83-90.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol20/iss2/6

This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry
Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons.

Henry Ford Hosp. Med. Journal
VoL 20, No. 2, 1972

Postmenopausal Osteoporosis: The evolution
of our concepts of its cause*
Harold M. Frost, M.D.**

Researchfindingsin the last 20 years concerning senile and postmenopausal
osteoporosis indicate that the skeletal condition associated with these diseases
arises because some systemic factor acts directly upon the bone marrow tissues.
There is a secondary tendency to accelerate loss of bone greater than in the
normal aging process. The loss occurs only on those surfaces in physical contact with the bone marrow tissue.

This article summarizes changes
during the past decade in our thinking
about the pathophysiology of postmenopausal osteoporosis which justify
this rather bold and possibly even novel
conclusion:

bone physiology and osteoporosis
which enjoyed some vogue about 30
years ago. We can then appreciate best
the significance of more recent developments.
The Assumptions

Postmenopausal
osteoporosis
emerges as an effect oj an underlying
bone marrow tissue disorder.

Approximately 30 years ago Fifller
Albright's pioneer writings reflected
the known facts that bone was a living
tissue, one resorbed by osteoclasts and
made by osteoblasts.^ It seemed logical
then that, in the operational sense,
osteoblasts throughout the skeleton
probably represented one single collection of cefls in the functional sense and
osteoclasts another (hence the "singularity" assumption). Furthermore, they
were assumed to function essentially
independently of each other in re-

To set the stage for this idea we
should review briefly some concepts of
"'Presented in part with a scientific exhibit
at the 1971 annual meetings of the American Academy of Orthopaedic Surgery and
the American Medical Association (in
collaboration with Dr. Charles Hanson).
**Chairman, Department of Orthopaedic
Surgery.
Reprint requests should be addressed to the
author care of Henry Ford Hospital
Detroit M I 48202
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sponding to systemic regulation by
blood-borne messengers of chemical or
hormonal nature (hence, the "independence" assumption). Further, and
of particular importance here, it was
assumed that this systemic regulation
acted either to directly depress osteoblasts (Albright's view), or to directly
stimulate osteoclasts (a view I favored
for a time, in the good company of
many others), leading thereby to the
deficient amount of bone tissue known
to characterize the osteoporotic skeleton. Unfortunately, so far, attempts to
find a medication which would selectively either stimulate the body's osteoblasts, or inhibit its osteoclasts have
been unsuccessful.
Why? I suggest that the problem
may be a consequence of the way we
were taught to think of the pathophysiology of the osteoporoses. Here is
some evidence supporting this contention:

distinguishable "packets" or remodeling units, which we have cafled Basic
Multicellular Units, (BMU).^ These
units bear several close analogies to
the nephrons in the kidney. With
great regularity, a typical bone remodeling BMU begins as a center of
bone resorption, characterized by active osteoclastic removal of a moiety
of bone amounting to approximately
.05mm'5 within less than a month.
Osteoclastic activity then subsides, new
osteoblasts materialize during the following days and proceed to fill in the
eroded cavity during the next three
months or so with a nearly equal
amount of newly-made bone.^
That sequence characterizes adult
lamellar bone remodeling in man as
well as in many other medium and
large-sized mammals (such as dogs,
goats, cats, monkeys, whales, rabbits,
sheep, horses, and cows). Also, it occurs on all of the periosteal, haversian,
cortical-endosteal and trabecular surfaces. Its twin properties of temporal
sequence and spatial discreteness persist alike in health and in a wide variety
of skeletal diseases. Within cortical
bone, the remodeling sites (termed
secondary osteons or haversian systems) resemble tubes some 150 to 250
microns in diameter "drilled" or oriented parallel to the longitudinal axis
of the bone. On endosteal surfaces
(both cortical and trabecular), the bone
remodeling centers have a semicircular,
shingle-like configuration. In skeletally
immature animals this simple morphological picture becomes mixed with
quite different forms of bone resorbing
and formative activities, ie, forms
peculiar to skeletal growth, which effectively overshadowed the remodeling

1) The "Independence" Assumption
While bone loss of great magnitude
may occur in some adult systemic
diseases, it usually proceeds only to a
certain point, so that the amount of
bony tissue remaining in the skeleton
tends to plateau. This implies some
connection between the capacities to
resorb and to form bone. (Here we
ignore localized processes, such as
bone tumors and infections.)
In that connection, histological studies at Henry Ford Hospital eventually
demonstrated a real connection between osteoclastic and osteoblastic
activity in both human and animal
material. Specifically, lamellar bone
turnover in adult humans occurs in
functionafly as well as histologically
84
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patterns from earlier morphologists and
physiologists.
In other words, in normal adult
bone remodeling one finds that bone
resorption and bone formation do not
occur as independent cellular activities.
This neatly explains why experimental
manipulations which after resorption in
intact animals also alter formation in
the same direction. This occurs ajter a
predictable titne lag needed for the
typical BMU to progress through its
resorption phase into its formation
phase (sigma-). Naturafly this coupling
wifl only be detected if an experiment
continues long enough for the "switchover" to occur, the necessary time varying from about two months in a healthy
rabbit to wefl beyond 10 years in some
cases of human osteomalacia. The cellular mechanisms that "couple" resorption to formation in the manner described remain unknown.
The BMU concept as well as the
BMU structure, in both the temporal
and morphological senses, suggest several possible ways in which the balance
between bone resorption and formation
within one BMU can change so as
to accelerate bone loss. Our own group
and others'^-^ have shown that in the
average BMU the balance between
the amount of bone removed by the
resorptive process and that replaced
by the following formation process
changes in a characteristic way as one
crosses the thickness of the cortex
from the periosteal to the endosteal
bone surfaces. An excess of formation
on the periosteal surface becomes a
negligible excess of resorption on haversian surface, which increases as
one moves toward the marrow cavity,
there to become a relatively large ex-

cess. We can summarize these simple
but important matters thus:
(i) In normal periosteal remodeling
BMU, slightly more bone is
replaced than is removed.
(ii) In normal haversian BMU,
slightly less bone is replaced
than is removed.
(iii) In normal cortical-endosteal
BMU, considerably less bone is
replaced than is removed.
In 1967 Wu, Jett and the author
estimated, on the basis of quantitative
histological measurements, that the
resorptive excess per endosteal BMU
in both normal and osteoporotic patients exceeds by approximately 70
times the resorptive excess found per
haversian BMU." (See Figure 1) A

65 yr.
Figure 1
Resorption relative to formation per
normal BMU on haversian and cortical-endosteal surfaces, expressed as relative
amounts of bone resorbed and made. Any
difference in their amount would tend to
make bone accumulate (in the case of an
excess of formation), or decrease (in the
case of a resorptive excess). This probably
accounts for expansion of the marrow cavity during adult life in man.
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relatively small further increase in the
magnitude of that excess could easfly
account for the actual losses of cortical
and trabecular bone observed in patients with osteoporosis. Beginning in
early adult life, an increase in the size
of each "bite" taken out of the skeleton
by the average endosteal BMU and
added up over a period of some 20
to 50 years could explain those losses.
Observe here the useful facts that,
whfle spongy bone represents only
about 20% of the total bone mass*,
it supplies more than 70% of the
total skeletal surface. Partly for that
reason any factor which increased the
net excess of bone resorption per endosteal BMU would subsequently reduce
the amount of trabecular bone faster
than it thinned the cortex.
The "independence" assumption, I
believe, proves partially false as it
applied to adult bone remodeling.
Osteoclasts and osteoblasts are somehow tethered to each other in the functional sense and by the BMU structure.

velope) envelop a measurable volume
of space and, finally, the endosteal envelope encompasses the marrow cavity
volume. Note that the volume encompassed by any of these three surfaces
in any person represents the arithmetic
sum of all previous bone resorption
and bone formation on that particular
surface. (Figure 2)

PERIOSTEAL
HAVERSIAN
TRABECULAR
ENDOSTEAL
CORTICAL
ENDOSTEAL

Figure 2
A rib section indicating the anatomical
location and meaning of the endosteal
surface, periosteal surface, and haversian
surface.

2) The "Singularity" Assumption

This "envelope concept" led quite
naturally to studies of changes in envelope cross-sectional sizes in standard
biopsy sites during growth, adult life,
aging and in a variety of congenital
and metabolic bone diseases including
the osteoporoses. In human rib sections, transverse expansions of both
marrow cavity and outside diameter
continue throughout life," although
longitudinal growth of bone ceases at
skeletal maturity. Initially controversial, that observation has been confirmed by many others ^ ^ lO'ii'i^. It
has been found also in human femur,
vertebra, metacarpal, clavicle, skull,
and entire skeletons, the only major

In the process of developing quantitative histological techniques fof analyzing bone dynamics around 1960, we
began to (a) use three anatomically
distinguishable types of skeletal bony
surfaces (ie, the periosteal, haversian,
and cortical-endosteal surfaces), (b)
define "envelopes" of bone tissue
space, and (c) indicate in those terms
the quantity of bone tissue in standard
diaphyseal bone cross sections. Thus,
the periosteal surfaces of the skeleton
periosteal envelope do indeed envelop
a definite and easfly measured volume
of bone and space. Simflarly, the haversian canal surfaces (or haversian en86

Postmenopausal Osteoporosis: The evolution of our concepts of its cause
exception being the radial diaphysis.^^
Figure 3 shows that the amount of
compacta uicreases during the growth
period because the rate of periosteal
expansion exceeds that of the marrow
cavity. Once skeletal maturity arrives,
the process reverses and the amount of
compacta begins gradually to decrease
because the marrow cavity expands
faster than the periosteal envelope.
During all that time, the intracortical
porosity or haversian space changes
little in relative size. Hence arises the
normal age-related thinning of the

compacta, termed by some the "physiologic" osteoporosis of aging and, in
the clinical sense, not really a disease
that requires treatment. Note that
trabeculae, surrounded entirely by the
marrow cavity, display the same agerelated loss. That loss, however, is
more pronounced because an expanding marrow cavity erodes only the
inner wall of the cortex surrounding
it. It is, at the same time, eroding all
four sides of a trabeculum.
Thus, the "singularity" assumption
did not apply to at least three operationally distinct collections of osteoclasts and the osteoblasts present on the
three envelopes of a normal skeleton.
The Envelope Matrix
Since the three skeletal envelopes
gain and lose bone independently during growth, adult life, aging, and in
a variety of diseases, we can depict
skeletal mass problems as morphological entities in terms of the respective
sizes of each of these envelopes.Ignoring the haversian envelope for
the present, one could construct a
matrix of all possible combinations
of periosteal and endosteal envelope
sizes in simple terms of size-states,
such as Increased, Normal, or Decreased. Figure 4 illustrates such a
matrix, portrays and lists examples of
five possible types of osteoporoses, ie,
envelope states which would represent
less bony tissue in the skeleton than
normal.
Where does postmenopausal osteoporosis (PMO) fit into such a scheme?
When examined from the morphological standpoint the bones from afflicted
patients reveal only enlargement of
the endosteal envelope, and no other
envelope size abnormality. (Square 2,
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Figure 3
Diagrammatic representation of the normal age-related changes in "envelope" sizes
in standard cross sections of the mid femur.
(Reprinted with permission of Howard
Duncan, M.D., and Z. F. Jaworski, M.D.
and the publishers, Tice's Practice of Medicine, Volume V, Chapter 52.
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Figure 4
Classification of possible combinations of the cross-sectional sizes of the periosteal and
endosteal envelopes, assuming arbitrarily that each can take only one of three states or
values-Increased, Normal or Decreased. The combination in square 5 is normal. The
combinations in squares 1, 2, 3, 6, and 9 represent various kinds of osteoporoses. Squares
4, 7 and 8 represent situations with too much bone. (Reprinted by permission: H. M . Frost,
Bone Dynamics in Osteoporosis and Osteomalacia, Charles C. Thomas, Springfield,
U.S.A. 1966).

of any such anatomically localized
intermediary, any blood-borne messengers acting directly on bone cells in
such a way as to enhance bone loss
should cause such loss on all bony
surfaces; yet, in postmenopausal osteoporosis that does not happen. Consequently I have proposed'^ that the
bone marrow which is altered by these
systemic factors in some way affects
the bone cells on the endosteal envelope, causing the marrow cavity expansion.
Conclusion
The specific marrow tissue pheno-

Figure 4) In other words, patients with
PMO and also those wflh several other
varieties of osteoporosis have lost only
that bone in physical contact with
the bone marrow. This fact implies
that accelerated marrow cavity expansion occurred during adult life, and
secondly, that whatever changes in
systemic "messengers" distributed by
the blood might ultimately prove to
cause this form of osteoporosis,"^-'''
16,17 ^j^gy (Jo not act directly on osteoclasts and osteoblasts. Rather, they
may well act on the soft tissues in the
marrow cavity. After all, in the absence
88
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mena which might cause the endosteal
bone loss in PMO seems to correlate
best with some aspect of bone marrow
activity. Several known associations
suggest this:
1. Hematopoietic activity in spongy
bone exceeds that in cortical
bone. So does osteoporosis.
2. During menstrual years women
have greater hematopoietic activity than men. They also exhibit
more osteoporosis.
3. Some have suggested that heparin might produce osteoporosis.
At Henry Ford Hospital, Drs.
Boy Frame and Robert Nixon
have shown that increased
numbers of mast cells, a source
of heparin, occur in the marrow of patients with osteoporo-

]

bone loss should concentrate on the
bone marrow and, particularly, on its
interactions with endosteal bone.
The following comments may help
keep these ideas in perspective:
(1) For reasons of space, we have
not mentioned here some additional,
characteristic, and consistently present
abnormal dynamic features which occur in the bony skeleton in postmenopausal and senfle osteoporoses.
(2) Only a small fraction of all
postmenopausal women who display
radiographic evidence of subnormal
bone density also have the clinical
disease of osteoporosis (consisting of
clinical disabflity due to spontaneous
structural failure). Our remarks here
apply only to osteoporosis, the disease,
which may ultimately prove to be no
more than an acceleration and augmentation of otherwise perfectly normal age-dependent skeletal trends.
(3) The association between the
menopause and this disease may prove
somewhat incidental, as it fundamentally resembles the "senile" osteoporosis seen in both women and men.
(4) At this time,- I suspect that
neither mast cells nor heparin directly
cause the osteoporosis under discussion
and that increased mast cefls in PMO
probably represent a more basic underlying abnormality in the bone marrow
which accounts for both phenomena.

sis. '
4. Osteoporosis in bones with red,
hematopoietic marrow usually
exceeds that in bones with fatty,
yellow marrow. This may explain
why it is more severe in the axial
skeleton (red marrow) than in
the appendicular (yellow marrow).
It is reasonable to conclude that
postmenopausal osteoporosis is a marrow tissue disorder which secondarily
affects endosteal bone. Therefore,
future investigations of the systemic
factors which govern its characteristic
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